With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas

 Stem cells derived from a human placenta hold the key to unlocking a myriad of potentials in regenerative medicine and are the focus of X-Prize and Singularity University founder Peter Diamandis’ new endeavor. Called Celularity, the startup is a spinout from Celgene, a global biopharmaceutical company creating gene therapies. Diamandis teamed up with Dr. Robert Hariri, the founder of… Read More

Powered by WPeMatico

The featured image was randomly selected. It is an unlikely coincidence if it is related to the post.